Peter Feinberg, Director at Immuneering Corp (IMRX), bought 20,000 shares at $4.35 ($87K) on 2026-01-12, disclosed to the SEC on 2026-01-14.
Open-market purchase of $87k IMRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| IMRX | BUY | 2025-09-30 | $36K | — | Filing → |
| IMRX | BUY | 2025-06-23 | $127K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $128K | — | Filing → |